Scholarlink

There is increasing evidence that non-invasive neuromodulation (NM) treatments such as repetitive transcranial magnetic stimulation (rTMS) may be a safe and effective treatment for substance use disorders (SUDs), including tobacco, alcohol, stimulants (e.g., cocaine and methamphetamine), cannabis, and opioids (reviewed in Mehta et al., Neuropsychopharmacol, 49: 649–680, 2024). Nonetheless, protocols for the optimization of safety and efficacy for rTMS methods are not well-developed, and the feasibility of these procedures for the management of (resistant) SUDs has not been established. This chapter will discuss ethical issues that are inherent in applying rTMS in people who are seeking acute treatment for SUDs.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Transcranial Magnetic Stimulation for Substance Use Disorders: Ethical Considerations

  • 章节

  • 发表日期：

    2025年

查看全文
  • Dhvani D. Mehta,
  • Melissa Hiebert,
  • Victor M. Tang,
  • Heather B. Ward,
  • Tony P. George

摘要

There is increasing evidence that non-invasive neuromodulation (NM) treatments such as repetitive transcranial magnetic stimulation (rTMS) may be a safe and effective treatment for substance use disorders (SUDs), including tobacco, alcohol, stimulants (e.g., cocaine and methamphetamine), cannabis, and opioids (reviewed in Mehta et al., Neuropsychopharmacol, 49: 649–680, 2024). Nonetheless, protocols for the optimization of safety and efficacy for rTMS methods are not well-developed, and the feasibility of these procedures for the management of (resistant) SUDs has not been established. This chapter will discuss ethical issues that are inherent in applying rTMS in people who are seeking acute treatment for SUDs.